751 related articles for article (PubMed ID: 19339067)
21. New approaches to molecular cancer therapeutics.
Collins I; Workman P
Nat Chem Biol; 2006 Dec; 2(12):689-700. PubMed ID: 17108987
[TBL] [Abstract][Full Text] [Related]
22. Identification of novel inhibitors of extracellular signal-regulated kinase 2 based on the structure-based virtual screening.
Park H; Bahn YJ; Jeong DG; Woo EJ; Kwon JS; Ryu SE
Bioorg Med Chem Lett; 2008 Oct; 18(20):5372-6. PubMed ID: 18835158
[TBL] [Abstract][Full Text] [Related]
23. Using X-ray crystallography in drug discovery.
Rowland RS
Curr Opin Drug Discov Devel; 2002 Jul; 5(4):613-9. PubMed ID: 12197319
[TBL] [Abstract][Full Text] [Related]
24. Can cell systems biology rescue drug discovery?
Butcher EC
Nat Rev Drug Discov; 2005 Jun; 4(6):461-7. PubMed ID: 15915152
[TBL] [Abstract][Full Text] [Related]
25. Chemogenomics: structuring the drug discovery process to gene families.
Harris CJ; Stevens AP
Drug Discov Today; 2006 Oct; 11(19-20):880-8. PubMed ID: 16997137
[TBL] [Abstract][Full Text] [Related]
26. Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H-pyrazole-3-carboxamide (AT7519), a novel cyclin dependent kinase inhibitor using fragment-based X-ray crystallography and structure based drug design.
Wyatt PG; Woodhead AJ; Berdini V; Boulstridge JA; Carr MG; Cross DM; Davis DJ; Devine LA; Early TR; Feltell RE; Lewis EJ; McMenamin RL; Navarro EF; O'Brien MA; O'Reilly M; Reule M; Saxty G; Seavers LC; Smith DM; Squires MS; Trewartha G; Walker MT; Woolford AJ
J Med Chem; 2008 Aug; 51(16):4986-99. PubMed ID: 18656911
[TBL] [Abstract][Full Text] [Related]
27. High-throughput X-ray crystallography for drug discovery.
Blundell TL; Patel S
Curr Opin Pharmacol; 2004 Oct; 4(5):490-6. PubMed ID: 15351354
[TBL] [Abstract][Full Text] [Related]
28. A decade of fragment-based drug design: strategic advances and lessons learned.
Hajduk PJ; Greer J
Nat Rev Drug Discov; 2007 Mar; 6(3):211-9. PubMed ID: 17290284
[TBL] [Abstract][Full Text] [Related]
29. Drugging the cancer kinome: progress and challenges in developing personalized molecular cancer therapeutics.
Workman P
Cold Spring Harb Symp Quant Biol; 2005; 70():499-515. PubMed ID: 16869789
[TBL] [Abstract][Full Text] [Related]
30. Recent progress in fragment-based lead discovery.
Schulz MN; Hubbard RE
Curr Opin Pharmacol; 2009 Oct; 9(5):615-21. PubMed ID: 19477685
[TBL] [Abstract][Full Text] [Related]
31. Initial compound selection for sequential screening.
Young SS; Lam RL; Welch WJ
Curr Opin Drug Discov Devel; 2002 May; 5(3):422-7. PubMed ID: 12058618
[TBL] [Abstract][Full Text] [Related]
32. RNA interference screening for the discovery of oncology targets.
Quon K; Kassner PD
Expert Opin Ther Targets; 2009 Sep; 13(9):1027-35. PubMed ID: 19650760
[TBL] [Abstract][Full Text] [Related]
33. The impact of diversity-based, high-throughput screening on drug discovery: "chance favours the prepared mind".
Snowden M; Green DV
Curr Opin Drug Discov Devel; 2008 Jul; 11(4):553-8. PubMed ID: 18600571
[TBL] [Abstract][Full Text] [Related]
34. Nuclear magnetic resonance in target profiling and compound file enhancement.
Sun C; Hajduk PJ
Curr Opin Drug Discov Devel; 2006 Jul; 9(4):463-70. PubMed ID: 16889229
[TBL] [Abstract][Full Text] [Related]
35. Computer-aided drug discovery and development.
Zhang S
Methods Mol Biol; 2011; 716():23-38. PubMed ID: 21318898
[TBL] [Abstract][Full Text] [Related]
36. Prioritizing hits from phenotypic high-content screens.
Low J; Stancato L; Lee J; Sutherland JJ
Curr Opin Drug Discov Devel; 2008 May; 11(3):338-45. PubMed ID: 18428087
[TBL] [Abstract][Full Text] [Related]
37. The impact of systems approaches on biological problems in drug discovery.
Hood L; Perlmutter RM
Nat Biotechnol; 2004 Oct; 22(10):1215-7. PubMed ID: 15470453
[No Abstract] [Full Text] [Related]
38. Computational chemistry approaches to drug discovery in signal transduction.
Fischer PM
Biotechnol J; 2008 Apr; 3(4):452-70. PubMed ID: 18412174
[TBL] [Abstract][Full Text] [Related]
39. Network pharmacology: the next paradigm in drug discovery.
Hopkins AL
Nat Chem Biol; 2008 Nov; 4(11):682-90. PubMed ID: 18936753
[TBL] [Abstract][Full Text] [Related]
40. NMR-based approaches for lead discovery.
Wyss DF; McCoy MA; Senior MM
Curr Opin Drug Discov Devel; 2002 Jul; 5(4):630-47. PubMed ID: 12197321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
